• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-PFO-035
Device Problem Unintended Movement (3026)
Patient Problem No Information (3190)
Event Date 01/09/2019
Event Type  Injury  
Event Description
On (b)(6) 2019, two pfo occluders (pfo) and an amplatzer atrial septal occluder (aso) were selected for implant.A 25mm pfo occluder was deployed in the septum, but quickly prolapsed into the right atrium while attached to the delivery cable.The device was removed and a 35mm pfo occluder was deployed and released.Ice observed the left atrial disc partially prolapsed into right atrium at aorta.Within approximately 3 minutes, the 35mm pfo occluder was found to have embolized into the right ventricle.A 24mm sizing balloon was used to sized the pfo defect.The balloon sizing on fluoroscopy was 23.9mm and by ice was 24.2mm.The physician decided to implant a 26mm aso through a 12 french delivery system.The 26mm aso device was seated well and no color flow was evident through or around device.A 35mm snare was used to secure the 35mm pfo occluder in the right ventricular outflow tract.A second 35mm snare was utilized to capture the female thread post of the occluder unsuccessfully.The 2nd snare also wrapped around the connecting waist of the occluder.A 20mm snare was then advanced through a large bore sheath, captured the female thread post of the 35mm pfo occluder, withdrew the device into the sheath and removed from body.The patient experienced episodes of desaturation with pulse oximetry as low as 40%.The patient was transferred to critical care area and placed on ecmo for continuous low saturations.On the following day, (b)(6) 2019, a ct was obtained and ruled out pulmonary embolism.While the patient was given a continuous iv infusion, tee observed saline (microbubbles) crossing the atrial septum slowly and abundantly apparently through the 26mm aso occluder.After much consideration, the patient was referred for surgical removal of 26mm aso and repair of septum with patch.The patient was subsequently removed from ecmo with satisfactory results.
 
Manufacturer Narrative
An event of embolization was reported.The investigation confirmed the device met functional and dimensional specifications when analyzed at abbott.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed.The cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer (Section G)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
Manufacturer Contact
stephanie o' sullivan
5050 nathan lane north
plymouth, MN 55442
6517565400
MDR Report Key8301638
MDR Text Key134887804
Report Number2135147-2019-00037
Device Sequence Number1
Product Code MLV
UDI-Device Identifier00811806011301
UDI-Public00811806011301
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/10/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/04/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date10/31/2021
Device Model Number9-PFO-035
Device Catalogue Number9-PFO-035
Device Lot Number5741658
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer02/01/2019
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Date Manufacturer Received03/15/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured11/21/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age64 YR
-
-